312 related articles for article (PubMed ID: 17079469)
1. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.
Chen D; Cui QC; Yang H; Dou QP
Cancer Res; 2006 Nov; 66(21):10425-33. PubMed ID: 17079463
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.
Chen D; Frezza M; Shakya R; Cui QC; Milacic V; Verani CN; Dou QP
Cancer Res; 2007 Oct; 67(19):9258-65. PubMed ID: 17909033
[TBL] [Abstract][Full Text] [Related]
4. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis.
Nam S; Smith DM; Dou QP
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1083-8. PubMed ID: 11588135
[TBL] [Abstract][Full Text] [Related]
5. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
6. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor proteasome activity by gold-dithiocarbamato complexes via both redox-dependent and -independent processes.
Zhang X; Frezza M; Milacic V; Ronconi L; Fan Y; Bi C; Fregona D; Dou QP
J Cell Biochem; 2010 Jan; 109(1):162-172. PubMed ID: 19911377
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of copper-dependent proteasome-inhibitory and apoptosis-inducing activities of novel pyrrolidine dithiocarbamate analogues.
Yu Z; Wang F; Milacic V; Li X; Cui QC; Zhang B; Yan B; Dou QP
Int J Mol Med; 2007 Dec; 20(6):919-25. PubMed ID: 17982703
[TBL] [Abstract][Full Text] [Related]
9. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D
J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581
[TBL] [Abstract][Full Text] [Related]
10. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".
Yang H; Shi G; Dou QP
Mol Pharmacol; 2007 Feb; 71(2):426-37. PubMed ID: 17093135
[TBL] [Abstract][Full Text] [Related]
11. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
12. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells.
Chen D; Daniel KG; Chen MS; Kuhn DJ; Landis-Piwowar KR; Dou QP
Biochem Pharmacol; 2005 May; 69(10):1421-32. PubMed ID: 15857606
[TBL] [Abstract][Full Text] [Related]
13. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
14. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
15. Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer.
Marx C; Yau C; Banwait S; Zhou Y; Scott GK; Hann B; Park JW; Benz CC
Mol Pharmacol; 2007 Jun; 71(6):1525-34. PubMed ID: 17392524
[TBL] [Abstract][Full Text] [Related]
16. Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells.
Xu B; Monsarrat B; Gairin JE; Girbal-Neuhauser E
Fundam Clin Pharmacol; 2004 Apr; 18(2):171-80. PubMed ID: 15066131
[TBL] [Abstract][Full Text] [Related]
17. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.
Foster PA; Ho YT; Newman SP; Kasprzyk PG; Leese MP; Potter BV; Reed MJ; Purohit A
Breast Cancer Res Treat; 2008 Sep; 111(2):251-60. PubMed ID: 17957467
[TBL] [Abstract][Full Text] [Related]
18. Sodium diethyldithiocarbamate, an AIDS progression inhibitor and a copper-binding compound, has proteasome-inhibitory and apoptosis-inducing activities in cancer cells.
Pang H; Chen D; Cui QC; Dou QP
Int J Mol Med; 2007 May; 19(5):809-16. PubMed ID: 17390087
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and apoptotic effects of two new gold(III) methylsarcosinedithiocarbamate derivatives on human acute myeloid leukemia cells in vitro.
Aldinucci D; Lorenzon D; Stefani L; Giovagnini L; Colombatti A; Fregona D
Anticancer Drugs; 2007 Mar; 18(3):323-32. PubMed ID: 17264766
[TBL] [Abstract][Full Text] [Related]
20. Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.
Nardon C; Schmitt SM; Yang H; Zuo J; Fregona D; Dou QP
PLoS One; 2014; 9(1):e84248. PubMed ID: 24392119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
